the First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
NCT Number: NCT02146976
The investigators designed a study to determine whether Propofol or Sevoflurane would provide same postoperative sleep quality in patients undergoing thyroidectomy.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Shenyang, Liaoning, 110001, China
The investigators designed a study to determine whether Propofol or Sevoflurane would provide same postoperative sleep quality in patients undergoing thyroidectomy.The bispectral index score (BIS) was monitored during the operation and the first postoperative night.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
introvenious infusion of propofol
sevoflurane (1.0-1.3 Minimum Alveolar Concentration)
Time frame: preoperation, first postoperative night
The primary outcome was the postoperative sleep quality, which was measured by the BIS-Vista monitor on the first night after surgery.
China Medical University, China
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07416773
Anesthesia Techniques, Postoperative Sleep Quality
Elâzığ, Elaziğ, Turkey (Türkiye)
View Trial DetailsNCT04827940
Neurologic Manifestations, Pain
Eskişehir, Odunpazarı, Turkey (Türkiye)
View Trial DetailsNCT04619979
General Anesthesia, Neurologic Manifestations
Shenyang, Liaoning, China
View Trial DetailsNCT04608435
Inflammation Function, Neurologic Manifestations
Shenyang, Liaoning, China
View Trial Details